Foehr Matthew W's Form 4 filing
Ligand Pharmaceuticals Inc (LGND) · filed Nov 12, 2021
- Accession no.
- 0000886163-21-000132
- Filed
- Nov 12, 2021
- Trade date
- Nov 11, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.82M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foehr Matthew WCIK 0001237556 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Stock | MOption exerciseAcquired | +1,028 | $100.38 | +$103,190.64 | 166,525 | Direct | |
| Nov 11, 2021 | Common Stock | MOption exerciseAcquired | +11,160 | $21.92 | +$244,627.2 | 177,685 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −11,160 | $163.02F1 | −$1,819,303.2 | 166,525 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Stock | MOption exerciseDisposed | −11,160 | $0.00 | $0 | 0 | Direct | |
| Nov 11, 2021 | Common Stock | MOption exerciseDisposed | −1,028 | $0.00 | $0 | 24,348 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.41 to $166.38, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.